Association of the Cholesterol,High-Density Lipoprotein,and Glucose Index with Mortality in Sepsis Patients: Two Cohort Studies Analysis

Abstract

Background

Sepsis is often complicated by insulin resistance and dyslipidemia. The Cholesterol, High-Density lipoprotein, and Glucose (CHG) index is a novel marker for insulin resistance, but its prognostic role in sepsis is unclear.

Methods

This retrospective cohort study was conducted using the MIMIC-IV database as the derivation cohort (n = 1325) and the eICU database as an independent external validation cohort (n = 953). The CHG index was calculated as Ln [total cholesterol × fasting glucose / (2 × high-density lipoprotein)]. Associations between CHG tertiles (MIMIC-IV: ≤5.2, >5.2-5.6, >5.6; eICU: ≤5.3, >5.3-5.9, >5.9) and 28-day/180-day all-cause mortality were assessed using restricted cubic spline regression, Kaplan-Meier analysis, and multivariable Cox models.

Results

The study comprised two cohorts: the MIMIC-IV cohort (n = 1,325, mean age 67.0 years) with 28-day and 180-day mortality rates of 24.5% and 33.4%, respectively; and the eICU validation cohort (n = 953) with a 28-day mortality rate of 14.4%. A linear positive association was found between CHG levels and mortality risk (P for nonlinearity >0.05). Each unit increase in CHG was associated with a 46% higher 28-day mortality risk in MIMIC-IV (HR = 1.46, 95% CI: 1.18-1.81) and a 41% higher risk in eICU (HR = 1.41, 95% CI: 1.11-1.79). After full adjustment, the highest CHG tertile independently predicted increased 28-day mortality (MIMIC-IV: HR = 1.52, 95% CI: 1.13-2.03; eICU: HR = 1.97, 95% CI: 1.25-3.11) and 180-day mortality in MIMIC-IV (HR = 1.38, 95% CI: 1.08-1.75). The predictive performance was comparable to the triglyceride-glucose index.

Conclusion

The CHG index is an independent prognostic marker for short- and long-term all-cause mortality in sepsis patients, exhibiting a linear positive association with risk. Monitoring the CHG index may help identify high-risk patients in the ICU.

Keywords

sepsis CHG index mortality insulin resistance MIMIC-IV

Get full access to this article

View all access options for this article.

References

Yang

Kang

Jung

, et al. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (sepsis-3). Clin Respir J. 2020;14(9):857–863.

Kim

Hur

Struck

, et al. Circulating biologically active adrenomedullin predicts organ failure and mortality in sepsis. Ann Lab Med. 2019;39(5):454–463.

Singer

Deutschman

Seymour

, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.

Reinhart

Daniels

Kissoon

, et al. Recognizing sepsis as a global health priority - A WHO resolution. N Engl J Med. 2017;377(5):414–417.

Evans

Rhodes

Alhazzani

, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143.

Brown

Walker

. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18(8):75.

Mehdi

Qureshi

Pervaiz

, et al. Endocrine and metabolic alterations in response to systemic inflammation and sepsis: A review article. Mol Med. 2025;31(1):16.

Boomer

Chang

, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–2605.

Taylor

Zhang

George

, et al. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: Systematic review, meta-analysis, and perspective of observational studies. EBioMedicine. 2024;100:104981.

10.

Hofmaenner

Kleyman

Press

, et al. The many roles of cholesterol in sepsis: A review. Am J Respir Crit Care Med. 2022;205(4):388–396.

11.

Barros-Pinkelnig

Arbous

, et al. High-density lipoprotein: A biomarker and therapeutic target in sepsis. Crit Care. 2025;29(1):453.

12.

Zhang

Chen

, et al. Acute glycemic variability and risk of mortality in patients with sepsis: A meta-analysis. Diabetol Metab Syndr. 2022;14(1):59.

13.

Wasyluk

Zwolak

. Metabolic alterations in sepsis. J Clin Med. 2021;10(11):2412.

14.

Wei

Qian

, et al. Exploring the U-shaped nonlinear relationship of CHG index with metabolic syndrome and mortality risks in metabolic syndrome patients. Lipids Health Dis. 2025;24(1):294.

15.

Vandenbroucke

von Elm

Altman

, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration. PLoS Med. 2007;4(10):e297.

16.

Mansoori

Nosrati

Dorchin

, et al. A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose (CHG) index. J Diabetes Investig. 2025;16(2):309–314.

17.

Simental-Mendía

Rodríguez-Morán

Guerrero-Romero

. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

18.

Zhang

, et al. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: A cohort study. Cardiovasc Diabetol. 2025;24(1):116.

19.

De Nardo

Labzin

Kono

, et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol. 2014;15(2):152–160.

20.

Zheng

Qian

Shi

, et al. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: Analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):307.

21.

Çatak

Konuk

ŞG

Hepsen

. The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy. J Diabetes Investig. 2025;16(8):1487–1494.

22.

Langley

Tsalik

van Velkinburgh

, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5(195):195ra95.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.04 MB